aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
A-Alpha Bio, founded with a mission to revolutionize therapeutic discovery, focuses on providing high-throughput, quantitative cell-based tools for measuring protein interactions. The company leverages synthetic biology and machine learning to measure, predict, and engineer protein-protein interactions at scale. Their core products and services are designed to accelerate the discovery and development of therapeutics, ultimately aiming to improve human health by providing high-resolution protein interaction data.
Notable figures affiliated with A-Alpha Bio include experts in synthetic biology and computational biology, though specific names are not provided. The company has achieved significant milestones in advancing the understanding of protein interactions, contributing to the broader field of therapeutic discovery. Their impact is evident in the enhanced efficiency and accuracy of drug development processes, positioning A-Alpha Bio as a key player in the biotechnology industry.
Operating Status
Active
Ownership Type(s)
Venture Capital
Main Product(s)
Protein Interactions
Technology
Machine Learning
Tags
Biotech
Model Types
Software
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
Global
When was A-Alpha Bio founded?
A-Alpha Bio was founded in 2017.
Where is A-Alpha Bio’s headquarters located?
A-Alpha Bio’s headquarters is located in Seattle, US.
When was A-Alpha Bio’s last funding round?
A-Alpha Bio’s most recent funding round was for $22.4M (USD) in July 2023.
How many employees does A-Alpha Bio have?
A-Alpha Bio has 55 employees as of Feb 5, 2024.
How much has A-Alpha Bio raised to-date?
As of July 05, 2023, A-Alpha Bio has raised a total of $49.6M (USD) since Jul 25, 2023.
Add Comparison
Total Raised to Date
$49.6M
USD
Last Update Jul 25, 2023
Last Deal Details
$22.4M
USD
Jul 25, 2023
Series A
Total Employees Over Time
55
As of Feb 2024
A-Alpha Bio Address
2101 4th Ave
Fifth Floor
Seattle,
98121
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts